Oxcarbazepine Suspension
Product Images NDC 72205-354

Product Visual Gallery

This gallery contains 20 technical images submitted to the FDA as part of the official labeling for Oxcarbazepine (NDC 72205-354). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Novadoz Pharmaceuticals Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Oxocarbazepine-bottle-lbl (Oxocarbazepine Bottle Lbl)

This text provides information about a suspension containing 300 mg of Oxcarbazepine, a product of Novadoz Pharmaceuticals LLC. It includes details on dosage, storage conditions, and manufacturer information. The usual dosage and storage instructions are mentioned, along with a recommendation to use the suspension within 7 weeks of opening the bottle. It also advises on shaking the suspension well before use and mentions the importance of keeping the medication out of reach of children. Additionally, it provides a contact number for prescribing information.*

FDA Label Image

Oxocarbazepine-carton-lbl (Oxocarbazepine Carton Lbl)

This text is a detailed description of an oxcarbazepine oral suspension medication. The medication is labeled with important instructions such as shaking well before use, storing in the original container, and keeping it out of reach of children. It provides information about the concentration of the suspension (300 mg/5 mL), dosage recommendations, storage conditions (20°C to 25°C), and the expiration period (use within 7 weeks of opening). The text also mentions that a Medication Guide should be provided separately to each patient, and it lists contact information for the manufacturer and distributor at the end.*

FDA Label Image

Oxocarbazepine-os-fig-01 (Oxocarbazepine Os Fig 01)

FDA Label Image

Oxocarbazepine-os-fig-02 (Oxocarbazepine Os Fig 02)

FDA Label Image

Oxocarbazepine-os-fig-03 (Oxocarbazepine Os Fig 03)

FDA Label Image

Oxocarbazepine-os-fig-04 (Oxocarbazepine Os Fig 04)

FDA Label Image

Oxocarbazepine-os-fig-05 (Oxocarbazepine Os Fig 05)

FDA Label Image

Oxocarbazepine-os-fig-06 (Oxocarbazepine Os Fig 06)

FDA Label Image

Oxocarbazepine-os-fig-07 (Oxocarbazepine Os Fig 07)

FDA Label Image

Oxocarbazepine-os-fig-08 (Oxocarbazepine Os Fig 08)

FDA Label Image

Oxocarbazepine-os-fig-09 (Oxocarbazepine Os Fig 09)

FDA Label Image

Oxocarbazepine-os-fig-10 (Oxocarbazepine Os Fig 10)

FDA Label Image

Oxocarbazepine-os-fig-11 (Oxocarbazepine Os Fig 11)

FDA Label Image

Oxocarbazepine-os-fig-12 (Oxocarbazepine Os Fig 12)

FDA Label Image

Oxocarbazepine-os-fig-13 (Oxocarbazepine Os Fig 13)

FDA Label Image

Oxocarbazepine-os-graph-01 (Oxocarbazepine Os Graph 01)

FDA Label Image

Oxocarbazepine-os-graph-02 (Oxocarbazepine Os Graph 02)

FDA Label Image

Oxocarbazepine-os-graph-03 (Oxocarbazepine Os Graph 03)

FDA Label Image

Oxocarbazepine-os-graph-04 (Oxocarbazepine Os Graph 04)

FDA Label Image

Oxocarbazepine-os-structure (Oxocarbazepine Os Structure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.